Chart pattern: Inverse Head and Shoulders (weekly)
▲ Broken out
Broke on Nov 06, 2026 · measured target $168.06 (+11%). Details →
Nov 5, 7:01 AM ET
Teleflex reported third quarter 2026 revenue of $567.8 million, up 0.2% from the prior year period, and up 3.0% on a pro forma adjusted constant currency basis. GAAP diluted EPS from continuing operations was $1.30, compared with a loss of $(1.32) a year earlier, and adjusted diluted EPS rose to $2.63 from $1.89. The company raised its 2026 adjusted diluted EPS guidance to $7.50 to $7.75 while lowering its GAAP revenue growth guidance to 13.2% to 14.2% because of foreign exchange rates.
- Q3 2026 adjusted diluted EPS from continuing operations was $2.63, versus $1.89 in the prior year period; GAAP diluted EPS was $1.30 versus $(1.32).
- 2026 adjusted diluted EPS guidance raised to $7.50 to $7.75; GAAP diluted EPS guidance raised to $2.84 to $3.09.
- 2026 GAAP revenue growth guidance reduced to 13.2% to 14.2% on foreign exchange; pro forma adjusted constant currency growth guidance maintained at 3.5% to 4.5%.
- About $350 million of common stock repurchased from July 1, 2026 through the release date, leaving $400 million under the current authorization; the OEM sale to Montagu and Kohlberg closed August 3, 2026 for $1.5 billion in cash.
Read the filing on SEC.gov ↗
Sep 8, 5:41 PM ET
Teleflex expanded its board from eight to nine directors and elected Sean M. Salmon to fill the new seat, effective September 8, 2026. Salmon previously led Medtronic's Cardiovascular portfolio, and the company says his appointment supports its governance and strategic priorities.
- Board increased from eight to nine directors; Sean M. Salmon elected to fill the new seat on September 8, 2026
- Salmon, age 61, founded consulting firm Zamboni Holdings, LLC in December 2025 and previously spent 21 years at Medtronic
- At Medtronic, Salmon was Executive Vice President and President, Cardiovascular, from January 2021 to September 2025
- Salmon joins the Growth and Operating Committee; he receives standard non-employee director compensation
Read the filing on SEC.gov ↗
Aug 6, 7:08 AM ET
Teleflex reported second-quarter 2026 revenue from continuing operations of $570.3 million, up 28.9% from the prior year, though GAAP diluted EPS fell to $0.96 from $1.54. The company cut its 2026 GAAP revenue growth and GAAP EPS guidance while raising its adjusted EPS guidance, and said it completed the sale of its OEM business and will start a $250 million accelerated share repurchase on August 7, 2026.
- Q2 2026 revenue of $570.3 million was up 28.9% reported and 4.7% on a pro forma adjusted constant currency basis; adjusted diluted EPS was $1.76 versus $1.73 a year earlier
- 2026 GAAP diluted EPS from continuing operations guidance was cut to $2.54 to $2.84; adjusted diluted EPS guidance was raised to $6.90 to $7.20
- 2026 GAAP revenue growth guidance was reduced to 13.40% to 14.40%, and pro forma adjusted constant currency growth guidance to 3.50% to 4.50%, which management attributed to a longer-than-expected integration of the Biotronik Vascular Inter
- OEM divestiture closed for $1.5 billion in cash; $700 million Term Loan A-2 was paid off, and $250 million of stock was repurchased in Q2 with a $250 million accelerated share repurchase set to begin August 7, 2026
Read the filing on SEC.gov ↗
Aug 3, 4:35 PM ET
Teleflex completed the sale of its Original Equipment Manufacturing and Development Services (OEM) business on August 3, 2026, for $1.5 billion in cash, subject to adjustment. The company estimates after-tax proceeds of about $1.25 billion and intends to use the net proceeds for debt reduction and share repurchases. Teleflex will give updated 2026 guidance with its second-quarter results on August 6, 2026.
- Sale closed August 3, 2026, for $1.5 billion in cash, subject to adjustment under the agreement dated December 9, 2025
- Estimated after-tax proceeds of about $1.25 billion
- Company priorities include $800 million of debt reduction and completing its $1 billion share repurchase authorization
- Updated 2026 financial guidance to be provided with second-quarter results on August 6, 2026
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.